Citius Oncology, Inc.

US$0.51As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:CTORHealthcare
Country USA
PE (Fwd) •••
TSR 4Y CAGR (53.99%)
Div yield —
ROE (126.58%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 3.57
PE TTM —
TSR TTM (70.89%)
Mkt cap US$53.88M
ROIC (68.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.548
7.49%
(83.66%)
Hold 10|8|10|5|5
1Q26
2Q26
3Q26
4Q26
Earnings per share$
0.01
0.01
0.01
0.01
11.41%
13.92%
22.59%
28.19%
Revenue$M
2.829
2.900
2.975
2.913
3.29%
6.90%
6.63%
2.66%
Peers (US$53.88M)
Cap (US$)
PE
54.50M
—
34.82M
—
Capital
TTM
5Y
10Y
Leveragex
0.126
(0.384)
(0.329)
EBIT/Intx
0.912
0.522
0.528
Own earn%
189.71
32.30
32.33
Sh yield%
34.99
8.67
7.30
Owners
Insiders/Inst%
11.72
39.12
Short interest%
4.51
SBC / revenue%
3.14
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
12–17
$1 testx
0.0
Incr. ROIC%
2